Pharmacologic treatment of heart failure has progressed over the last two decades, but regimens have become more complex.? With pharmacogenetics, the time is rapidly approaching when information on genetic variability will be used to predict therapeutic response and select the right drug for the right patient.? In this issue of Heart Failure Clinics, several leading pioneers of this next revolution in heart failure treatment present the current state-of-the-art on the use of genomic information to target therapeutics.? The issue begins with two articles on the basics of what every clinician...